1246818-16-5
Chemical Structure
Pyridoxal phosphate-d5
- CAS No.: 1246818-16-5
- Formula:C8H5D5NO6P
- Molecular Weight:252.17
IUPAC Name: (4-formyl-5-hydroxy-6-(methyl-d3)pyridin-3-yl)methyl-d2 dihydrogen phosphate
InChIKey: NGVDGCNFYWLIFO-SGEUAGPISA-N
SMILES: C(OP(=O)(O)O)(C=1C(C=O)=C(O)C(C([2H])([2H])[2H])=NC1)([2H])[2H]
Biological Activity: Pyridoxal phosphate-d5 is the deuterium labeled Pyridoxal phosphate. Pyridoxal phosphate is the active form of vitamin B6, acts as an inhibitor of reverse transcriptases, and is used for the treatment of tardive dyskinesia[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Pyridoxal phosphate-d5 | 99.30% | Pyridoxal phosphate-d5 is the deuterium labeled Pyridoxal phosphate. Pyridoxal phosphate is the active form of vitamin B6, acts as an inhibitor of reverse transcriptases, and is used for the treatment of tardive dyskinesia. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pyridoxal phosphate (Standard) | 99.88% | Pyridoxal phosphate (Standard) is the analytical standard of Pyridoxal phosphate. This product is intended for research and analytical applications. Pyridoxal phosphate is the active form of vitamin B6, acts as an inhibitor of reverse transcriptases, and is used for the treatment of tardive dyskinesia. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pyridoxal phosphate | 99.95% | Pyridoxal phosphate is the active form of vitamin B6, acts as an inhibitor of reverse transcriptases, and is used for the treatment of tardive dyskinesia. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [Content Brief]
- [2]. Modak MJ. Pyridoxal 5' phosphate: a selective inhibitor of oncornaviral DNA polymerases. Biochem Biophys Res Commun. 1976 Jul 12;71(1):180-7. [Content Brief]